Stockton, United Kingdom

Curtis Swift

This inventor holds 1 USPTO granted patent. Top assignee: Achieve Life Sciences, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Curtis Swift. Retrieved from https://idiyas.com/inventor/curtis-swift

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Curtis Swift: Innovator in Cytisine Purity Assessment

Introduction

Curtis Swift is a notable inventor based in Stockton, GB. He has made significant contributions to the field of analytical methods, particularly in assessing the purity of cytisine. His work is essential for ensuring the quality and efficacy of this compound, which has various applications in medicine.

Latest Patents

Curtis holds a patent for "Analytical methods of assessing cytisine purity." This patent describes methods of assessing the purity of cytisine using gradient chromatography at multiple wavelengths. This innovative approach enhances the accuracy and reliability of purity assessments, which is crucial for pharmaceutical applications.

Career Highlights

Curtis is currently employed at Achieve Life Sciences, Inc., where he continues to develop and refine analytical techniques. His expertise in chromatography and analytical methods has positioned him as a valuable asset to his team and the broader scientific community.

Collaborations

Curtis collaborates with talented coworkers, including Katie Williams and Nigel Richardson. Their combined efforts contribute to advancements in the field of analytical chemistry and the development of effective methodologies.

Conclusion

Curtis Swift's work in the assessment of cytisine purity exemplifies the importance of innovation in the pharmaceutical industry. His contributions not only enhance the quality of medicinal compounds but also pave the way for future advancements in analytical methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…